DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khojasteh-Bakht, S. C.
Right arrow Articles by Nelson, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khojasteh-Bakht, S. C.
Right arrow Articles by Nelson, S. D.

Vol. 27, Issue 5, 574-580, May 1999

Metabolism of (R)-(+)-Pulegone and (R)-(+)-Menthofuran by Human Liver Cytochrome P-450s: Evidence for Formation of a Furan Epoxide

Siamak C. Khojasteh-Bakht, Weiqiao Chen, Luke L. Koenigs, Raimund M. Peter, and Sidney D. Nelson

Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, Washington

(R)-(+)-Pulegone, a monoterpene constituent of pennyroyal oil, is a hepatotoxin that has been used in folklore medicine as an abortifacient despite its potential lethal effects. Pulegone is metabolized by human liver cytochrome P-450s to menthofuran, a proximate hepatotoxic metabolite of pulegone. Expressed human liver cytochrome (CYP) P-450s (1A2, 2A6, 2C9, 2C19, 2D6, 2E1, and 3A4) were tested for their ability to catalyze the oxidations of pulegone and menthofuran. Expressed CYP2E1, CYP1A2, and CYP2C19 oxidized pulegone to menthofuran, with respective Km and Vmax values of 29 µM and 8.4 nmol/min/nmol P-450 for CYP2E1, 94 µM and 2.4 nmol/min/nmol P-450 for CYP1A2, and 31 µM and 1.5 nmol/min/nmol P-450 for CYP2C19. The human liver P-450s involved in the metabolism of menthofuran are the same as pulegone except for the addition of CYP2A6. These P-450s were found to oxidize menthofuran to a newly identified metabolite, 2-hydroxymenthofuran, which is an intermediate in the formation of the known metabolites mintlactone and isomintlactone. Based on studies with 18O2 and H218O, 2-hydroxymenthofuran arises predominantly from a dihydrodiol formed from a furan epoxide. CYP2E1, CYP1A2, and CYP2C19 oxidized menthofuran with respective Km and Vmax values of 33 µM and 0.43 nmol/min/nmol P-450 for CYP2E1, 57 µM and 0.29 nmol/min/nmol P-450 for CYP1A2, and 62 µM and 0.26 nmol/min/nmol P-450 for CYP2C19.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
T. M. Alvarez-Diez and J. Zheng
DETECTION OF GLUTATHIONE CONJUGATES DERIVED FROM 4-IPOMEANOL METABOLISM IN BILE OF RATS BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
Drug Metab. Dispos., December 1, 2004; 32(12): 1345 - 1350.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L.-J. Chen, E. H. Lebetkin, and L. T. Burka
METABOLISM OF (R)-(+)-MENTHOFURAN IN FISCHER-344 RATS: IDENTIFICATION OF SULFONIC ACID METABOLITES
Drug Metab. Dispos., October 1, 2003; 31(10): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L.-J. Chen, E. H. Lebetkin, and L. T. Burka
COMPARATIVE DISPOSITION OF (R)-(+)-PULEGONE IN B6C3F1 MICE AND F344 RATS
Drug Metab. Dispos., July 1, 2003; 31(7): 892 - 899.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Miyazawa, M. Shindo, and T. Shimada
Oxidation of 1,8-Cineole, the Monoterpene Cyclic Ether Originated From Eucalyptus Polybractea, by Cytochrome P450 3A Enzymes in Rat and Human Liver Microsomes
Drug Metab. Dispos., February 1, 2001; 29(2): 200 - 205.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.